Research & Development: Page 75
-
PharmaVoice Team/PharmaVoice
PharmaTrax
SALES, MARKETING, AND R&D TRENDS AFFECTING THE HEALTHCARE INDUSTRY GENERICS SECTOR Expected to Double by 2007 According to Datamonitor, by 2007 the generics market is expected to be valued at $57 billion, more than twice its estimated value of $27 billion in 2001. Researchers at the company c...
By PharmaVoice Team • Feb. 22, 2009 -
PharmaVoice Team/PharmaVoice
Raise Your Voice: Letters
LETTERS Two critical areas of success Missed Opportunities Your article on “The Patient Pipeline” highlighted many of the difficulties in patient accrual and retention. Unfortunately the solutions in my opinion missed two critical success factors. As CEO and cofounder of MCSI, the largest U.S.-b...
By PharmaVoice Team • Feb. 22, 2009 -
Explore the Trendline➔
Stock via Getty Images
TrendlineClinical trial diversity
As pharma wises up to the fact that the current playbook for improving clinical trial diversity has yet to make a meaningful impact, the quest is on to refine that approach.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Funding in a closed space The healthcare private equity market was down in 2002, and industry experts don’t expect a gr eat deal of improvement in 2003. Venture capital firms are sit ting on massive funds and are still doing deals, but according to Russell LaMontagne, president and founder of Cor...
By Taren Grom • Feb. 22, 2009 -
PharmaVoice Team/PharmaVoice
Joe Krivulka: A Reliable Guy
Joe Krivulka Small opportunities are turning into big business for Joe Krivulka and Reliant Pharmaceuticals LLC, the company he cofounded just two years ago. Mr. Krivulka is seizing the opportunity to breathe new life into products being cast off by the pharmaceutical giants. “Big pharma has prod...
By Kim Ribbink • Feb. 21, 2009 -
PharmaVoice Team/PharmaVoice
A Therapeutic Path to Success
The marketers of Cox2 antiinflammatory drugs, have enjoyed two years of recordbreaking sales, but with new products poised to come to market, the challenge will be to hold onto their strong positions. Cox2 inhibitors entered the market with a splash with the launch of Celebrex in 1998. The Pharma...
By Virginia Kirk • Feb. 21, 2009 -
PharmaVoice Team/PharmaVoice
The Toll of Terror
was never going to be a stellar year for global economies, but until September 11, 2001, many in the business world predicted a quick recovery. Those hopes have faded somewhat as consumer spending, rising unemployment, and business uncertain ty plague some sectors. The biopharmaceuti cal industry...
By PharmaVoice Team • Feb. 21, 2009 -
PharmaVoice Team/PharmaVoice
E-Media
NEW ELECTRONIC AND WEBBASED APPLICATIONS, SITES, AND TECHNOLOGIES Free drug samples handed out to patients in a physician’s office soon may be replaced with printed vouchers that physicians retrieve online for patients to redeem at a pharmacy free of charge. MedManage Systems Inc., an innovator i...
By PharmaVoice Team • Feb. 17, 2009 -
PharmaVoice Team/PharmaVoice
What's New
In a move to solidify its commitment to multicul tural and multiethnic communities, Torre Lazur McCann HealthCare Worldwide has created a new Multicultural Healthcare Marketing Business unit to focus on specific needs and values.The standalone group,a part of theTorre Lazur McCann corridor,pro vi...
By PharmaVoice Team • Feb. 17, 2009 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Aging female population presents NEW CHALLENGES in HRT MARKET The growing number of postmenopausal women translates into new challenges for clinicians and is leading to increased focus on the hormone replacement therapy market. Hormone Replacement Therapy, a study from Decision Resources Inc., id...
By PharmaVoice Team • Feb. 17, 2009 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
America’s pharmaceutical industry is helping the process of healing the nation in the wake of September 11th. Within hours of the terrorist attacks on New York and Washington, America’s pharmaceutical companies responded with medicines and vaccines, supplies for workers and rescuers, and aid for ...
By Taren Grom • Feb. 17, 2009 -
PharmaVoice Team/PharmaVoice
Table of Contents
4 S e p t e m be r / O c t o b e r 2 00 1 PharmaVOICE The promise of things to come The Internet’s future potential is in its infinite ability to allow marketers to develop personalized messages 48 Conquering the market, one segment at a time Cytyc’s launch of the ThinPrep System is making an imp...
By PharmaVoice Team • Feb. 16, 2009 -
PharmaVoice Team/PharmaVoice
Conquering the Market, One Segment at a Time
To achieve market share for its cervical cancer test, Cytyc marketers must switch physicians, labs, and managed care organizations from the established standard of care. By Virginia Kirk PATRICK SULLIVAN, CEO AND PRESIDENT A best in class sales team and superior product attributes are driving sal...
By Virginia Kirk • Feb. 16, 2009 -
PharmaVoice Team/PharmaVoice
The Promise of Things to Come
The full impact of the Internet’s capability to create strategic marketing and selling tactics in the pharmaceutical industry has yet to be realized. The Internet’s impact on pharma ceutical marketing and sales has been negligi ble to date, but when used to complement traditional tactics, the fut...
By Norman Selby • Feb. 16, 2009 -
PharmaVoice Team/PharmaVoice
Training on the Brand Manager Level: a Path Less Traveled
“The marketplace was screaming bloody murder for our product, and our competitor was eating our lunch as it tried to gobble up market share with a similar product. I was forced to work around the clock just to stay afloat. I was managing strategic planning for the brand, creating Dear Doctor lett...
By Deborah Ruriani • Feb. 16, 2009 -
PharmaVoice Team/PharmaVoice
Global Harmony Comes to Drug Development
That document — called the common technical document or CTD — is now being accepted by regulatory agencies in the United States, Europe, and Japan as part of a transition phase. Consensus was reached by the international pharmaceutical community in May of this year. This document will eventually ...
By Denise Myshko • Feb. 16, 2009 -
PharmaVoice Team/PharmaVoice
E-Media
NEW ELECTRONIC AND WEBBASED APPLICATIONS, SITES, AND TECHNOLOGIES RapidTrials.com, launched by PCRS Inc., is the first Webbased platform to provide realtime bench mark metrics on trial progress for research centers. The pro gram helps drive revenue, study programs, and marketing research projects...
By PharmaVoice Team • Feb. 12, 2009 -
PharmaVoice Team/PharmaVoice
What's New
WHAT’S NEW NEW HEALTHCARERELATED PRODUCTS, SERVICES, AND COMPANIES The OmniLog ID Microbial Identification System, which includes proprietary software and sophisticat ed hardware, is designed to automate and simplify the process of characterizing and identifying a wide range of aerobic bacteria. ...
By PharmaVoice Team • Feb. 12, 2009 -
PharmaVoice Team/PharmaVoice
Table of Contents
6 J u l y / A u gu s t 20 01 PharmaVOICE CSOs: Not just hired guns Contract sales organizations have come a long way to stay a step ahead of their clients’ needs 34 Unleashing the power of Nexium AstraZeneca marketers are positioning the company’s new proton pump inhibitor to replace Prilosec, th...
By PharmaVoice Team • Feb. 11, 2009 -
PharmaVoice Team/PharmaVoice
CSOs: Not Just Hired Guns
Contract sales organizations have come a long way to stay one step ahead of their clients’ needs. Today, the contract sales industry is more than putting bodies in motion. No longer are contract sales organizations just “hired guns” employed for a temporary territory fix. Since 1995, when contrac...
By PharmaVoice Team • Feb. 11, 2009 -
PharmaVoice Team/PharmaVoice
Making Investigators Top of Mind
Finding experienced and trained physician investigators will become more of a challenge in the future as new technologies and advances in genomics increase the number of drugs in development. 8,000 In just a few short years, this will be the projected short fall of clinical investigators. In fact...
By Denise Myshko • Feb. 10, 2009 -
PharmaVoice Team/PharmaVoice
Table of Contents
We invite you to explore the digital edition of PharmaVOICE magazine. The interactive format allows you to easily read, share with friends, and click on podcasts, videos, webinars, whitepapers, and Website links to access additional resources. Getting started with your digital edition is this eas...
By PharmaVoice Team • Jan. 28, 2009 -
PharmaVoice Team/PharmaVoice
Electronic Data Capture Turns a Corner ... At Last!
Dennis Constantinou, Senior Director, Oracle Health Sciences New systems that make trial participation easier for investigation sites spur adoption. Today, setting up an EDC system at an investigative site requires only a standard PC with a Web browser and an Internet connection. With the average...
By Dennis Constantinou • Jan. 28, 2009 -
PharmaVoice Team/PharmaVoice
Harriet Robinson: A Shot of Daring
Throughout her life and career, Dr. Harriet Robinson has dared to take on challenges. Today, she is focusing her skills and determination on one of the most sought-after goals in global healthcare: developing a vaccine to prevent HIV/AIDS. After almost 40 years in the lab, Dr. Harriet Robinson is...
By Kim Ribbink • Jan. 28, 2009 -
PharmaVoice Team/PharmaVoice
Video Detailing: 10 Years in the Making
With the proliferation of broadband and advances in technology, e-promotional and educational online activities are on the rise. Detail videos may not have revolutionized the pharma industry in quite the way MTV has revolutionized the music industry, but the medium is gaining traction 10 years af...
By Robin Robinson • Jan. 28, 2009 -
PharmaVoice Team/PharmaVoice
Last Word
We are honored to receive this prestigious Enterprise award from Eastern Technology Council, says Robert Broeze, Ph.D., President and CEO of Laureate Pharma. Dr. Broeze, who is with Dr. Michiel Ultee, VP of Process Sciences, in front of an Applikon 20L Bioreactor, says the award validates the com...
By PharmaVoice Team • Jan. 28, 2009
Previous
